nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acknowledgements
|
|
|
2002 |
104 |
3 |
p. vii- 1 p. |
artikel |
2 |
Author Index
|
|
|
2002 |
104 |
3 |
p. 277- 1 p. |
artikel |
3 |
Changes of attention and memory in a group of patients with multiple sclerosis
|
Janculjak, Davor |
|
2002 |
104 |
3 |
p. 221-227 7 p. |
artikel |
4 |
Compartmentalization of the immune response in the central nervous system and natural history of multiple sclerosis. Implications for therapy
|
Massacesi, Luca |
|
2002 |
104 |
3 |
p. 177-181 5 p. |
artikel |
5 |
Editorial Note
|
|
|
2002 |
104 |
3 |
p. ix- 1 p. |
artikel |
6 |
Epidemiology of multiple sclerosis in Croatia
|
Materljan, Eris |
|
2002 |
104 |
3 |
p. 192-198 7 p. |
artikel |
7 |
Immunomodulatory treatment of MS in Slovenia
|
Sega-Jazbec, Sasa |
|
2002 |
104 |
3 |
p. 249-250 2 p. |
artikel |
8 |
Interferon β treatment in relapsing–remitting multiple sclerosis. A review
|
Grigoriadis, Nikolaos |
|
2002 |
104 |
3 |
p. 251-258 8 p. |
artikel |
9 |
Long-term benefits of early and high doses of interferon β-1a treatment in relapsing–remitting multiple sclerosis
|
Chofflon, Michel |
|
2002 |
104 |
3 |
p. 244-248 5 p. |
artikel |
10 |
Mechanisms of demyelination and tissue destruction in multiple sclerosis
|
Lassmann, Hans |
|
2002 |
104 |
3 |
p. 168-171 4 p. |
artikel |
11 |
MRI monitoring of MS in clinical trials
|
Miller, David H |
|
2002 |
104 |
3 |
p. 236-243 8 p. |
artikel |
12 |
Multiple sclerosis 2001
|
Poser, Charles M |
|
2002 |
104 |
3 |
p. 165-167 3 p. |
artikel |
13 |
Multiple sclerosis and interferon β-1b, past, present and future
|
Horowski, Reinhard |
|
2002 |
104 |
3 |
p. 259-264 6 p. |
artikel |
14 |
Multiple sclerosis: from basic immunopathology to immune intervention
|
Miller, Ariel |
|
2002 |
104 |
3 |
p. 172-176 5 p. |
artikel |
15 |
Newer long-term treatments for multiple sclerosis
|
Pryse-Phillips, William |
|
2002 |
104 |
3 |
p. 265-271 7 p. |
artikel |
16 |
Quality of life and cost of multiple sclerosis
|
Miltenburger, Carolin |
|
2002 |
104 |
3 |
p. 272-275 4 p. |
artikel |
17 |
The differential diagnosis of multiple sclerosis
|
Brinar, Vesna V |
|
2002 |
104 |
3 |
p. 211-220 10 p. |
artikel |
18 |
The genetics of multiple sclerosis
|
Dessa Sadovnick, A |
|
2002 |
104 |
3 |
p. 199-202 4 p. |
artikel |
19 |
The natural history of early onset multiple sclerosis: comparison of data from Moscow and Vancouver
|
Gusev, Eugin |
|
2002 |
104 |
3 |
p. 203-207 5 p. |
artikel |
20 |
The natural history of untreated multiple sclerosis in Iceland. A total population-based 50 year prospective study
|
Benedikz, John |
|
2002 |
104 |
3 |
p. 208-210 3 p. |
artikel |
21 |
The symptomatic treatment of multiple sclerosis
|
Poser, Charles M |
|
2002 |
104 |
3 |
p. 231-235 5 p. |
artikel |
22 |
The worldwide prevalence of multiple sclerosis
|
Pugliatti, Maura |
|
2002 |
104 |
3 |
p. 182-191 10 p. |
artikel |
23 |
Using cognitive performance to investigate neurodegenerative disease
|
Spilich, George J |
|
2002 |
104 |
3 |
p. 228-230 3 p. |
artikel |